Supporting moderation: beer’s structural advantage in the no-alcohol space

A Luxembourg court ruling that a drink cannot be labeled “gin” unless it contains at least 37.5% ABV underscores regulatory distinctions between spirits and beer, while industry data show strong momentum in lower- and no-alcohol beer: no-alcohol beer made up 95% of all no-alcohol adult beverages globally in 2024 and volumes are projected to reach 10 billion liters by 2030. Regional consumption metrics (UK: 38% semi-regular use up from 29% in 2022; Spain 40%; Germany 44%) and NielsenIQ’s finding that 94% of U.S. no-alcohol buyers also buy alcohol point to moderation rather than abstention, representing a durable growth and product-mix opportunity for brewers who have invested heavily in de-alcoholization technologies and single-serve packaging.

Analysis

Market structure: The Luxembourg ruling crystallizes a structural advantage for beer — no/low-alc beer already represents ~95% of no‑alcohol adult beverage volumes in 2024 and is forecast to hit 10bn L by 2030, which favors large brewers (scale R&D, distribution) and can/packaging suppliers that monetize single‑serve formats. Winners: AB InBev (BUD), Heineken (HEINY ADR), Molson Coors (TAP) and Ball Corp (BALL) for cans; losers: small craft brewers without dealcoholization capex and certain wine/spirits categories whose identity is alcohol‑dependent.

Risk assessment: Tail risks include EU/UK regulatory tightening (e.g., new labeling/tax rules) or a consumer taste reversal — low probability but could remove price premia or impose excise equivalents; operational risk includes high capex for low‑alc tech and energy costs (natural gas/electricity spikes). Timeframe: immediate negligible sales impact, 3–12 months for product rollouts and marketing, 12–36 months for measurable share shifts and margin effects.

Trade implications: Expect share shifts to scale players and packaging providers; pricing power may compress for craft brands as incumbents subsidize trial. Capitalize with selective long exposure to BUD/HEINY and BALL over 6–24 months while shorting select small cap/CRAFT names that disclose <2% no‑alc revenue and face shelf displacement.

Contrarian angles: Consensus underestimates ancillary beneficiaries (canning, CO2 logistics, cold‑chain retail shelf space) and the likelihood of M&A consolidation over 12–36 months. Beware unintended consequences: heavy promotion to build no‑alc trial could compress industry gross margins by 100–300bps before volume benefits materialize.

Key Decisions for Investors

• Establish a 2–3% long position in Anheuser‑Busch InBev (BUD) over a 12–24 month horizon to capture scale advantages in no/low‑alc beer; set a stop‑loss at 12% and target a 15–30% upside driven by share gains or margin re‑rating.
• Initiate a 1–2% long position in Ball Corporation (BALL) for 6–18 months to play persistent single‑serve can demand; consider augmenting if Q2–Q4 2025 can order bookings rise >5% QoQ—target +20% return, stop‑loss 10%.
• Pair trade: go long BUD (1% portfolio) and short Boston Beer Co. (SAM) (1%) for 6–12 months to exploit scale vs craft shelf displacement; reassess if SAM reports >5% sequential improvement in no/low revenue penetration.
• Options: Buy 6–9 month call spreads (debit) on BUD roughly 10–20% OTM (buy lower strike / sell higher strike) to limit capital while harvesting re‑rating if incumbents report no/low revenue contribution growth >100 bps QoQ in next two quarters.